Follow Us

  • Grey Instagram Icon
  • Grey LinkedIn Icon
  • Grey Twitter Icon
  • Grey Facebook Icon

Contact Us

Subscribe to the S2BN 

© Copyright 2019 by Science to Business Network. 

Past Events - Toronto

May 29, 2019

Trends and Challenges: Why We Need a Patient-centered Approach to Innovate in Healthcare

Patient-centered care has been identified as an important concept by organizations around the world. In recent years, there has been a culture change towards patient-centered care which has resulted in greater collaboration with patients and patient groups and better recognition that individuals have unique needs. From a patient perspective, patient-centered care may translate into better access to medication, much needed support through complex therapeutic regimens and a less stressful treatment experience. For caregivers and healthcare providers, patient- centered approaches can help reduce the burden of care, while for manufacturers focusing on optimizing the patient experience can help patients achieve better outcomes which can lead to greater access opportunities. This event will explore the evolving landscape, challenges and opportunities regarding patient-centered care in Canada.


Session Objectives

  • Discuss the value of patient-centered care, patient engagement and patient advocacy on innovation in healthcare

  • Explore challenges faced by patients in accessing medication and navigating the Canadian healthcare system

  • Evaluate collaborative opportunities for enhancing the patient experience

 

Host: Bruce Seet Ph.D, MBA
 

With Guest Panelists:

 

Lisa Machado (Executive Director, Canadian CML Network)
Nicole Serena (Director, PSP Consulting Services, MATRIX Healthcare Strategists Inc.)

Alan Birch (Director, Oncology Drug Access Navigators of Ontario)

Mar 27, 2019

The journey from science to business can be challenging; even more so for women, who are often underrepresented in the field. This year, International Women in Science, Technology, Engineering and Mathematics (STEM) Day fell on February 11th and International Women's Day fell on March 8th, 2019. In celebration of these two days and encouragement of continuous innovation in Canada, this event will provide insight into the career journeys of successful Canadian women in science, innovation and entrepreneurship.

 

Session Objectives

  • Review the current state of women in science, innovation and entrepreneurship in Canada

  • Discuss challenges and key learnings of the panelists' career journeys from academia to industry

  • Highlight opportunities for gender equality and diversity in science innovation and entrepreneurship

Dec 05, 2018

Pharma Insights with Paul Petrelli: The Evolution of Organizational Leadership in the Pharmaceutical Industry

Session Objectives

  • Review emerging trends in the healthcare sector that are driving the need to adapt

  • Highlight leadership skills for future growth and adaptability in a dynamic industry

  • Outline the opportunities to navigate and drive effective change in the healthcare and pharmaceutical industry of tomorrow

Host: Brian Knight, Ph.D, MBA

With Guest Speaker: Paul Petrelli (General Manager, Jazz Pharmaceuticals; Chairman, Executive Committee, BIOTECanada)​

Nov 07, 2018

The AI Revolution: Disrupting the Path from Drug Discovery to Patient Care

Artificial intelligence (AI) in healthcare involves the use of algorithms and software to mimic human cognition in analyzing complex medical data. It has the potential to transform every step of the path from drug discovery to patient care by increasing efficiency and effectiveness, while decreasing cost. Are we on the cusp of an AI revolution? During this session, experts from leading AI companies will profile the current state of AI in healthcare, review the challenges and opportunities facing this burgeoning sector, and discuss how Canada can leverage its research infrastructure to become a world leader in AI technology. 


Session Objectives

  • Profile how AI is disrupting business areas from drug discovery to patient diagnosis and treatment

  • Discuss the challenges and opportunities in unleashing the power of AI while balancing data integrity, privacy, and a complex regulatory environment

  • Explore how Canada can leverage its public and private research infrastructure to become a global leader in AI

 

Host: Bruce Seet, Ph.D, MBA
 

With Guest Panelists:

 

Simon Smith (Chief Growth Officer, BenchSci)
Naheed Khurji (President and CEO, Cyclica)

John Reeves (Partner, Chief Medical Officer, conversationHEALTH)

Sep 26, 2019

Patient Access to Medications: Future of the Canadian Reimbursement Landscape

Although critical to commercial success, market access remains one of the pharmaceutical industry’s greatest challenges. Following regulatory approval by Health Canada, market access professionals must navigate the complex pricing and reimbursement landscape to ensure therapies are publicly and privately available at a price that is affordable, yet supports continued innovation. The industry will soon be facing new challenges when the Patented Medicine Prices Review Board (PMPRB) updates its 30-year old regulatory framework, intending to lower drug prices for Canadians. This session will provide insight into emerging trends in market access, current challenges and opportunities, and the impact of proposed changes to the PMPRB. 


Session Objectives

  • Highlight emerging trends in the Canadian market access and reimbursement environment.

  • Profile the proposed changes to the PMPRB framework and the potential impact on
    patients, payers, and sponsors.

  • Explore the challenges and opportunities in delivering both value and timely access to
    cutting-edge medicines to all Canadians.

 

Host: Bruce Seet, Ph.D, MBA
 

With Guest Panelists:

 

Bennett Lee (Head, Market Access, Sanofi Genzyme)
Joan McCormick (Principal, Price Regulation Consulting, IQVIA)

Alex Chambers (Director, pan-Canadian Oncology Drug Review [pCODR])

1 / 4

Please reload

S2BN